novo nordisk glp 1 Nordisk's oral GLP-1 drug didn't work on Alzheimer's as hoped, but don't call it a failure GLP-1 RA education

In the SURMOUNT-1 trial, participants without diabetes lost an average of 15-20% of their body weight over 72 weeks at the 10 mg and 15 mg doses, though results may vary in different populations

In people struggling with weight, this signal is often weak or delayed, leading to overeating and energy imbalance

GLP-1 is most well-known for the ways it impacts metabolism and digestion, including its effect on insulin, blood sugar, stomach emptying, and how full you feel after eating

This simple act of tracking removes the guesswork and ensures you stay on your prescribed schedule

In sum, most studies suggest that GLP-1 RAs do not increase the risk of suicide, with some indicating potential benefits